AXIM (AXIM Biotechnologies) Common Stock: $0.04 Mil (As of Jun. 2025)


What is AXIM Biotechnologies Common Stock?

AXIM Biotechnologies AXIM Common Stock is $0.04 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

AXIM Biotechnologies's quarterly common stock increased from Dec. 2024 ($0.03 Mil) to Mar. 2025 ($0.03 Mil) and increased from Mar. 2025 ($0.03 Mil) to Jun. 2025 ($0.04 Mil).

AXIM Biotechnologies's annual common stock increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.03 Mil) and increased from Dec. 2023 ($0.03 Mil) to Dec. 2024 ($0.03 Mil).

AXIM Biotechnologies Common Stock Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Common Stock Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.03 0.03

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.03 0.03 0.04

AXIM Biotechnologies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.04 Mil mean?
AXIM Biotechnologies (AXIM) has a Common Stock of $0.04 Mil as of Jun. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on AXIM Biotechnologies and its competitors.
Is AXIM Biotechnologies' Common Stock too high?
AXIM Biotechnologies' current Common Stock is $0.04 Mil.
How does AXIM Biotechnologies' Common Stock compare to HEPA and SCNI?
AXIM Biotechnologies' Common Stock of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current Common Stock is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Common Stock of $0.04 Mil. The current Common Stock is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Common Stock is $0.04 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.